Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00045149
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Early research (Phase 1)Study completedNCT00179608
What this trial is testing

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

Who this might be right for
Malignant Melanoma
Celgene 28
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Not applicableStudy completedNCT01531608
What this trial is testing

Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma

Who this might be right for
Melanoma
University of Virginia 20
Early research (Phase 1)Study completedNCT00095108
What this trial is testing

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaKidney NeoplasmsMetastases
ZymoGenetics 43
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Not applicableLooking for participantsNCT00040352
What this trial is testing

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

Who this might be right for
MelanomaDysplastic Nevus Syndrome
National Cancer Institute (NCI) 3,000
Testing effectiveness (Phase 2)Study completedNCT02662725
What this trial is testing

Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases

Who this might be right for
MelanomaBrain Metastasis
University Hospital, Lille 73
Testing effectiveness (Phase 2)Looking for participantsNCT06999980
What this trial is testing

Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Who this might be right for
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia 494
Early research (Phase 1)Study completedNCT00121680
What this trial is testing

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Eisai Inc. 115
Testing effectiveness (Phase 2)Study completedNCT00004141
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Chicago 46
Testing effectiveness (Phase 2)Study completedNCT01497808
What this trial is testing

RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA

Who this might be right for
Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Study completedNCT00107159
What this trial is testing

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 37
Early research (Phase 1)Study completedNCT01863108
What this trial is testing

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Who this might be right for
MelanomaTumor VaccinesEffects of Immunotherapy
University Hospital, Grenoble 9
Not applicableUnknownNCT03683550
What this trial is testing

Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma

Who this might be right for
Melanoma
University Hospital, Essen 836
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06848088
What this trial is testing

Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Early research (Phase 1)Ended earlyNCT06034860
What this trial is testing

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Who this might be right for
Non Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more
Molecular Templates, Inc. 15
Not applicableStudy completedNCT03356470
What this trial is testing

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

Who this might be right for
Melanoma
University of Wisconsin, Madison 5
Next Page